Comparison between Advanced Enzyme Technologies IPO and RBL Bank IPO.
Advanced Enzyme Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while RBL Bank IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Advanced Enzyme Technologies IPO is up to ₹411.49 Cr whereas the issue size of the RBL Bank IPO is up to ₹1,212.97 Cr. The final issue price of Advanced Enzyme Technologies IPO is ₹896.00 per share and of RBL Bank IPO is ₹225.00 per share.
| Advanced Enzyme Technologies IPO | RBL Bank IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹880.00 per share | ₹224.00 per share |
| Issue Price (Upper) | ₹896.00 per share | ₹225.00 per share |
| Issue Price (Final) | ₹896.00 per share | ₹225.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹86.00 per share | |
| Market Lot Size | 16 shares | 65 shares |
| Fresh Issue Size | 5,60,405 shares | 3,70,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹50.19 Cr | up to ₹832.50 Cr |
| OFS Issue Size | 40,34,470 shares | 1,69,09,628 shares |
| OFS Issue Size (Amount) | up to ₹361.30 Cr | up to ₹380.47 Cr |
| Issue Size Total | 45,94,875 shares | 5,39,09,628 shares |
| Issue Size Total (Amount) | up to ₹411.49 Cr | up to ₹1,212.97 Cr |
Advanced Enzyme Technologies IPO opens on Jul 20, 2016, while RBL Bank IPO opens on Aug 19, 2016. The closing date of Advanced Enzyme Technologies IPO and RBL Bank IPO is Jul 22, 2016, and Aug 23, 2016, respectively.
| Advanced Enzyme Technologies IPO | RBL Bank IPO | |
|---|---|---|
| Anchor Bid Date | Jul 19, 2016 | Aug 18, 2016 |
| Issue Open | Jul 20, 2016 | Aug 19, 2016 |
| Issue Close | Jul 22, 2016 | Aug 23, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Aug 01, 2016 | Aug 31, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Advanced Enzyme Technologies IPO P/E ratio is , as compared to RBL Bank IPO P/E ratio of .
| Advanced Enzyme Technologies IPO | RBL Bank IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 63.11 | |||||
| Promoter Shareholding (Post-Issue) | 49.52 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹2000.41 Cr. | ₹8320.70 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 28.14% |
In the Advanced Enzyme Technologies IPO Retail Individual Investors (RII) are offered 15,99,565 shares while in RBL Bank IPO retail investors are offered 15,99,565 shares. Qualified Institutional Buyers (QIB) are offered 9,14,038 shares in Advanced Enzyme Technologies IPO and 1,07,81,926 shares in RBL Bank IPO.
| Advanced Enzyme Technologies IPO | RBL Bank IPO | |
|---|---|---|
| Anchor Investor Reservation | 13,71,053 shares | 1,61,72,887 shares |
| Market Maker Reservation | ||
| QIB | 9,14,038 shares | 1,07,81,926 shares |
| NII | 6,85,528 shares | 80,86,445 shares |
| RII | 15,99,565 shares | 1,88,68,370 shares |
| Employee | 24,691 shares | |
| Others | ||
| Total | 45,94,875 shares | 5,39,09,628 shares |
Advanced Enzyme Technologies IPO subscribed 116.02x in total, whereas RBL Bank IPO subscribed 69.62x.
| Advanced Enzyme Technologies IPO | RBL Bank IPO | |
|---|---|---|
| QIB (times) | 94.03x | 85.08x |
| NII (times) | 393.10x | 198.06x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 11.67x | 5.70x |
| Employee (times) | 1.73x | |
| Other (times) | ||
| Total (times) | 116.02x | 69.62x |
